Clinical Trial Update: Clinical Study Evaluating the Safety and Efficacy of Roflumilast in Type 2 Diabetic Patients With Diabetic Neuropathy [Phase 3]

View source ↗

Summary

Clinical trial evaluating safety and efficacy of roflumilast in adults with type 2 diabetes and diabetic neuropathy has completed Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: Tanta University | Conditions: Type 2 Diabetes (Adult Onset), Diabetic Neuropathies | Phase 3 | Status: COMPLETED